| Product Code: ETC7507063 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hungary Parkinsons Disease Market Overview |
3.1 Hungary Country Macro Economic Indicators |
3.2 Hungary Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Hungary Parkinsons Disease Market - Industry Life Cycle |
3.4 Hungary Parkinsons Disease Market - Porter's Five Forces |
3.5 Hungary Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Hungary Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Hungary Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Hungary Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Hungary Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Hungary Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Hungary |
4.2.2 Growing awareness about the disease and available treatment options |
4.2.3 Technological advancements in the diagnosis and treatment of Parkinson's disease |
4.3 Market Restraints |
4.3.1 High cost associated with Parkinson's disease treatment |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Hungary |
4.3.3 Side effects of existing Parkinson's disease medications |
5 Hungary Parkinsons Disease Market Trends |
6 Hungary Parkinsons Disease Market, By Types |
6.1 Hungary Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Hungary Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Hungary Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Hungary Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Hungary Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Hungary Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Hungary Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Hungary Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Hungary Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Hungary Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Hungary Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Hungary Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Hungary Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Hungary Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Hungary Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Hungary Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Hungary Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Hungary Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Hungary Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Hungary Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Hungary Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Hungary Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Hungary Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Hungary Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Hungary Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Hungary Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Hungary Parkinsons Disease Market Export to Major Countries |
7.2 Hungary Parkinsons Disease Market Imports from Major Countries |
8 Hungary Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease patients in Hungary |
8.2 Number of clinical trials for Parkinson's disease treatments in Hungary |
8.3 Percentage of Parkinson's disease patients receiving timely and appropriate care |
9 Hungary Parkinsons Disease Market - Opportunity Assessment |
9.1 Hungary Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Hungary Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Hungary Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Hungary Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Hungary Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Hungary Parkinsons Disease Market - Competitive Landscape |
10.1 Hungary Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Hungary Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here